|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02652 CF PHARMTECH
Nominal 
() Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| ROAA (%) | 1.762% | 2.951% | -4.866% |
| ROAE (%) | 2.281% | 3.581% | -5.731% |
| Return on Capital Employed (%) | 2.081% | 3.292% | -5.626% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Gross Profit Margin (%) | 80.851% | 82.223% | 76.607% |
| EBITDA Margin (%) | 13.266% | 13.109% | -10.267% |
| Pre-tax Profit Margin (%) | 3.157% | 4.033% | -20.226% |
| Net Profit Margin (%) | 3.470% | 5.702% | -14.149% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Current Ratio (X) | 1.882 X | 2.887 X | 3.530 X |
| Quick Ratio (X) | 1.690 X | 2.677 X | 3.324 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Total Liabilities / Total Assets(%) | 25.396% | 19.832% | 15.099% |
| Total Debt / Total Assets (%) | 6.282% | 1.930% | 0.148% |
| Net Debt / Total Assets (%) | -0.226% | -4.290% | -7.223% |
| Total Debt / Shareholders' Funds (%) | 8.421% | 2.408% | 0.174% |
| Long Term Debt / Shareholders' Funds (%) | 6.196% | 2.110% | 0.028% |
| Net Debt / Shareholders' Funds (%) | -0.302% | -5.351% | -8.508% |
| Net Cash / (Debt) ($) | 2.840M | 48.699M | 73.334M |
| Net Cash / (Debt) per share ($) | -- | -- | -- |
| Total Debt / Capital Employed (%) | 7.805% | 2.274% | 0.171% |
| Interest Coverage Ratio (X) | 11.759 X | 137.018 X | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Inventory Turnover (Day) | 130.591 Day | 118.801 Day | 126.435 Day |
| Receivables Turnover (Day) | 9.009 Day | 3.873 Day | 9.343 Day |
| Payables Turnover (Day) | 14.352 Day | 13.226 Day | 13.713 Day |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 21,088 |
| %Change | -33.531% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB -- |